BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19563860)

  • 21. Cadmium-exposed population in Mae Sot District, Tak Province: 2. Prevalence of renal dysfunction in the adults.
    Limpatanachote P; Swaddiwudhipong W; Mahasakpan P; Krintratun S
    J Med Assoc Thai; 2009 Oct; 92(10):1345-53. PubMed ID: 19845243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nephrotoxic action of cadmium].
    Wrońska-Nofer T; Hałatek T
    Pol Tyg Lek; 1993 May 3-10; 48(18-19):404-6. PubMed ID: 8309818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of cadmium as an environmental health problem.
    Järup L; Akesson A
    Toxicol Appl Pharmacol; 2009 Aug; 238(3):201-8. PubMed ID: 19409405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cadmium, metallothionein and renal tubular toxicity.
    Nordberg M; Jin T; Nordberg GF
    IARC Sci Publ; 1992; (118):293-7. PubMed ID: 1303954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal effects evolution in a Chinese population after reduction of cadmium exposure in rice.
    Wu X; Liang Y; Jin T; Ye T; Kong Q; Wang Z; Lei L; Bergdahl IA; Nordberg GF
    Environ Res; 2008 Oct; 108(2):233-8. PubMed ID: 18692183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of benchmark dose for renal dysfunction in a cadmium non-polluted area in Japan.
    Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
    J Appl Toxicol; 2006; 26(4):351-5. PubMed ID: 16791912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The reference dose for subchronic exposure of pigs to cadmium leading to early renal damage by benchmark dose method.
    Wu X; Wei S; Wei Y; Guo B; Yang M; Zhao D; Liu X; Cai X
    Toxicol Sci; 2012 Aug; 128(2):524-31. PubMed ID: 22610606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis of cadmium toxicity.
    Nath R; Prasad R; Palinal VK; Chopra RK
    Prog Food Nutr Sci; 1984; 8(1-2):109-63. PubMed ID: 6385135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetyl-beta-D-glucosaminidase (NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted areas.
    Moriguchi J; Inoue Y; Kamiyama S; Horiguchi M; Murata K; Sakuragi S; Fukui Y; Ohashi F; Ikeda M
    Toxicol Lett; 2009 Oct; 190(1):1-8. PubMed ID: 19467302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone mineral density is related with previous renal dysfunction caused by cadmium exposure.
    Chen X; Zhu G; Jin T; Lei L; Liang Y
    Environ Toxicol Pharmacol; 2011 Jul; 32(1):46-53. PubMed ID: 21787729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
    Min KS; Onosaka S; Tanaka K
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safe levels of cadmium intake to prevent renal toxicity in human subjects.
    Satarug S; Haswell-Elkins MR; Moore MR
    Br J Nutr; 2000 Dec; 84(6):791-802. PubMed ID: 11177195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of metallothionein gene isoforms expression as biomarkers in cadmium exposure].
    Chang XL; Jin TY; Chen L; Lei LJ; Zhou YF
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):12-5. PubMed ID: 16600086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of benchmark dose for bone damage and renal dysfunction in a Chinese male population occupationally exposed to lead.
    Sun Y; Sun D; Zhou Z; Zhu G; Lei L; Zhang H; Chang X; Jin T
    Ann Occup Hyg; 2008 Aug; 52(6):527-33. PubMed ID: 18567606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical concentration of cadmium for renal toxicity in rats.
    Tohyama C; Sugihira N; Saito H
    J Toxicol Environ Health; 1987; 22(3):255-9. PubMed ID: 3682016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary N-acetyl-beta-D-glucosaminidase isoenzymes as biomarker of renal dysfunction caused by cadmium in a general population.
    Jin T; Nordberg G; Wu X; Ye T; Kong Q; Wang Z; Zhuang F; Cai S
    Environ Res; 1999 Aug; 81(2):167-73. PubMed ID: 10433849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cadmium-induced nephropathy in the development of high blood pressure.
    Satarug S; Nishijo M; Ujjin P; Vanavanitkun Y; Moore MR
    Toxicol Lett; 2005 May; 157(1):57-68. PubMed ID: 15795094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoporosis and renal dysfunction in a general population exposed to cadmium in China.
    Jin T; Nordberg G; Ye T; Bo M; Wang H; Zhu G; Kong Q; Bernard A
    Environ Res; 2004 Nov; 96(3):353-9. PubMed ID: 15364604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in cadmium-related health effects in persons with high environmental exposure in northwestern Thailand: a five-year follow-up.
    Swaddiwudhipong W; Limpatanachote P; Mahasakpan P; Krintratun S; Punta B; Funkhiew T
    Environ Res; 2012 Jan; 112():194-8. PubMed ID: 22033168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary mercury and biomarkers of early renal dysfunction in environmentally and occupationally exposed adults: a three-country study.
    Jarosińska D; Horvat M; Sällsten G; Mazzolai B; Dabkowska B; Prokopowicz A; Biesiada M; Barregård L
    Environ Res; 2008 Oct; 108(2):224-32. PubMed ID: 18684440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.